海洋-伦哈特综合征在壮成长过程中的发展. 一个案例报告
Momo Saito1, Yosuke Okada1, Fumi Uemura1
1The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.
Internal medicine (Tokyo, Japan)
|December 17, 2025
概括
本案例研究突出了一个罕见的同时存在的甲状腺毒性病例,该病例发生在一名患有甲状腺壮大症的老年患者身上. 有效的管理包括治疗积症和Marine-Lenhart综合征,使激素水平正常化.
科学领域:
- 内分泌学 在内分泌学.
- 内部医学 内部医学
- 在瘤学瘤学.
背景情况:
- 巨症是一种由生长激素过量引起的疾病,通常涉及下垂体瘤.
- 老年患者可能表现出非典型的壮症症状和同时存在的内分泌疾病.
- 中枢甲状腺功能低下症是已知的下垂体瘤的并发症.
研究的目的:
- 报告一位老年女性患者罕见的壮症与Marine-Lenhart综合征共存的病例.
- 强调诊断挑战和同时发生内分泌异常的管理策略.
- 强调对患有壮病的老年患者进行警监测的重要性.
主要方法:
- 通过手术切除一个转状垂体瘤.
- 药理管理包括levothyroxine,索马托斯塔丁模拟物和thiamazole.
- 激素水平监测,包括胰岛素类生长因子-1 (IGF-1) 和甲状腺功能测试.
主要成果:
- 手术后IGF-1的正常化最初是异常的,需要进一步调查.
- 甲状腺毒性病 (Marine-Lenhart综合征) 的发展观察到,尽管对甲状腺功能低下症进行了levothyroxine治疗.
- 与索马托斯坦类同类药物和蒂亚马联合治疗导致IGF-1和甲状腺功能正常化.
结论:
- 同时存在的甲状腺毒性病是一种罕见但显著的并发症在壮病患者,特别是老年人.
- 老年人的非典型表现需要全面的内分泌评估和监测.
- 综合治疗方法对于管理壮病中复杂的荷尔蒙失衡至关重要.
更多相关视频
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
362
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362
Heart Failure III: Clinical Manifestations
440
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
440
Rheumatic Heart Disease I: Introduction
407
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
407
Cardiomyopathy II: Dilated Cardiomyopathy
436
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
436
Mitral Stenosis I: Introduction
386
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
386
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
325
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
325


